Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03976895
Other study ID # 69HCL19_0333
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 13, 2021
Est. completion date November 2022

Study information

Verified date October 2021
Source Hospices Civils de Lyon
Contact Florent BAUDIN, Dr
Phone 04 72 12 97 35
Email florent.baudin@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Acute viral bronchiolitis is the leading cause of community-acquired acute respiratory failure in developed countries (20 000 to 30 000 hospitalizations each year in France). Between 5% and 22% of these children are hospitalized in a critical care unit to benefit from a respiratory support. Non-invasive ventilation, in particular the nasal Continuous Positive Airway Pressure (nCPAP), reduces the work of breathing in children with bronchiolitis and is associated with decreased morbidity and hospitalization costs compared with invasive ventilation. Nowadays, this technique is considered as the gold standard in the pediatric intensive care units (PICU) in France. High Flow Nasal Cannula (HFNC) has been proposed as an alternative to the nCPAP because of its better tolerance and simplicity of implementation. However, the proportion of failure remains high (35 to 50%), providing only a partial response to the care of these children, especially prior to the PICU. In a physiological study (NCT02602678, article published), it has been demonstrated that prone position (PP) decrease, by almost 50%, the respiratory work of breathing and improve the respiratory mechanics in infants hospitalized in intensive care units for bronchiolitis. Investigators hypothesize that prone position, during High Flow Nasal Cannula (HFNC), would significantly reduce the use of non-invasive ventilation (nCPAP and others) or invasive ventilation, as compared to supine position during HFNC, in infants with moderate to severe viral bronchiolitis.


Recruitment information / eligibility

Status Recruiting
Enrollment 452
Est. completion date November 2022
Est. primary completion date November 2022
Accepts healthy volunteers No
Gender All
Age group N/A to 6 Months
Eligibility Inclusion Criteria: - Infant under 6 months - Hospitalized in critical care unit (continuous monitoring unit or intensive care unit) - With a clinical diagnosis of acute viral bronchiolitis (criterion of the American Academy of Pediatrics 2014) - m-WCAS score = 3 and / or hypercapnic acidosis with pH <7.35 and pCO2> 50mmHg (6.7 kPa) - Informed consent signed by at least one of the parents with oral consent of the other parent (and / or legal guardian) recorded in the medical file. Exclusion Criteria: - Infant admitted with criteria for invasive or non-invasive ventilation (hypercapnic acidosis with pH <7.25 without ventilatory support and/or hypoxia with impossibility of maintaining SpO2> 92% whatever the FiO2 and/or more than 3 significant apneas per hour and/or severe consciousness disorder) - Patient already positioned in the prone position before randomization - Significant comorbidities with a history of respiratory pathology (bronchodysplasia with ventilatory support), Ear Nose and Throat pathology (pharyngolaryngomalacia) or neuromuscular and / or hemodynamically significant congenital heart disease. - Contraindication to Prone position : recent abdominal surgery (laparoschisis or omphalocele) or recent sternotomy - Patient who is not affiliated (or does not benefit from) to a national social security system

Study Design


Intervention

Procedure:
Supine position (SP)
Infants under high flow nasal cannula (HFNC) will be positioned in the supine position. Patients may be positioned temporarily in lateral position between periods of supine position to limit ventilatory disorders, as it is usually done in critical care units during bronchiolitis.
Prone position (PP)
Infants under high flow nasal cannula (HFNC) will be placed in the prone position during at least 24 hours over the first 48 hours. The positioning will be standardized (chest on the bed plan and abdomen cleared) and children should be placed in the prone position immediately after randomization. Patients may be positioned temporarily in lateral position between periods of prone position to limit ventilatory disorders, as it is usually done in critical care units during bronchiolitis.

Locations

Country Name City State
France Réanimation pédiatrique et unité de surveillance continue - Hôpital Femme Mère Enfant - Hospices Civils de Lyon Bron
France CHU de Caen, Service de réanimation et surveillance continue pédiatrique Caen
France CH CHAMBERY Unité de surveillance continue pédiatrique Chambéry
France Hôpital d'Enfants CHU de Dijon Service de réanimation pédiatrique Dijon
France CH ANNECY GENEVOIS Unité de surveillance continue pédiatrique Épagny
France CH VILLEFRANCHE Service de pédiatrie néonatologie Gleizé
France CHU GRENOBLE Service de réanimation pédiatrique Hôpital Couple Enfant La Tronche
France CHU MONTPELLIER Service de réanimation pédiatrique Montpellier
France CHU Nantes Unité de surveillance continue pédiatrique Hôpital mère-enfant Nantes
France CHU LENVAL NICE Service de réanimation pédiatrique Nice
France Hôpital Necker Enfant Malade, Paris Service de Réanimation et surveillance continue médicochirurgicales Paris
France CHU SAINT-ETIENNE Service de réanimation pédiatrique Saint-Priest-en-Jarez
France CRHU Nancy Réanimation Pédiatrique Spécialisée VandÅ“uvre-lès-Nancy

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of ventilated children in each of the 2 groups Indications for the use of ventilation (invasive or non-invasive ventilation) will be standardized in both groups (based on the interregional protocol for the management of bronchiolitis):
Clinical aggravation defined by an increase = 1 point of the m-WCAS score
Persistence of hypercapnic acidosis with pH =7.30 and pCO2= 8 kPa or FiO2> 60% under HFNC at 2 L/kg/min
More than 2 significant apneas per hour (apnea with desaturation <90% and / or bradycardia <90 / min)
Consciousness disorder
Anytime over the first 3 days after inclusion
3 days
Secondary Proportion of failure Failure is defined as:
HFNC failure (composite failure criterion validated by an independent committee)
worsening of mWCAS score = 1 point
hypercapnic acidosis (pH =7.30 and pCO2=8kPa)
significant apnea (apnea with desaturation <90% and / or bradycardia <90/min)
Anytime over the first 3 days after inclusion
3 days
Secondary Causes of failure Failure is defined as:
HFNC failure (composite failure criterion validated by an independent committee)
worsening of mWCAS score = 1 point
hypercapnic acidosis (pH =7.30 and pCO2=8kPa)
significant apnea (apnea with desaturation <90% and / or bradycardia <90/min)
Anytime over the first 3 days after inclusion
3 days
Secondary Duration of ventilation Duration of ventilation (high flow nasal cannula, invasive, non-invasive) in hours.
This data will be collected at critical care unit discharge.
maximum 3 months
Secondary Length of stay Length of stay in days. This data will be collected at hospital discharge. maximum 3 months
Secondary Oxygenation evaluation Evolution of FiO2 and SpO2/FiO2 ratio between inclusion and H2. 2 hours
Secondary Oxygenation evaluation Evolution of FiO2 and SpO2/FiO2 ratio between inclusion and H12. 12 hours
Secondary Oxygenation evaluation Evolution of FiO2 and SpO2/FiO2 ratio between inclusion and H24. 24 hours
Secondary Tolerance evaluation Proportion of skin lesions, vomiting/regurgitation and exclusive enteral nutrition.
This data will be collected at critical care unit discharge.
maximum 3 months
Secondary Variation EDIN score (Scale of pain and discomfort of the newborn) between inclusion and after 2 hours Scale ranges to 0 from 15 and is a combination of criteria:
Face: Relaxed=0 to Permanent tightness or prostrate face,frozen or purple face=3
Body: Relaxed=0 to Permanent agitation,tightness of extremities and stiffness of limbs or very poor and limited motor skills with fixed body=3
Sleep:Easily, extended and calm=0 to No sleep=3
Relationship:Smile to the angels,smile answer,attentive to the listening=0 to Refuses contact,no relationship possible,howl or moan without any stimulation=3
Comfort: Do not need comfort=0 to Inconsolable,desperate sucking=3
2 hours
Secondary Evaluation of the feasibility of maintaining the position Proportion of children in the prone position repositioned definitively in the supine position before performing the cumulative 24 hours of prone position, cumulative hours of prone position in the first 48 hours 48 hours
See also
  Status Clinical Trial Phase
Completed NCT01777347 - Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis Phase 3
Not yet recruiting NCT01437956 - KL-6 Protein as a Biomarker of Lung Injury in Viral Bronchiolitis N/A
Completed NCT01873144 - High Flow Therapy vs Hypertonic Saline in Bronchiolitis Phase 3
Completed NCT05899894 - NAVA in Infants With Acute Viral Bronchiolitis: A Feasibility Study N/A
Completed NCT02460614 - Effects of Rhinopharyngeal Retrograde Clearance in Children With Acute Viral Bronchiolitis N/A
Completed NCT03738501 - Slow Expiratory Technique to Improve Alimentation in Children With Bronchiolitis N/A
Active, not recruiting NCT01295398 - Influence of the Nebulizer on the Clinical Efficacy of Hypertonic Saline 3% in Children Aged Less Than 18 Months and Hospitalized With Acute Viral Bronchiolitis N/A